Skip to main content

Advertisement

Table 1 Summary of GEO cohort characteristics

From: The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

  GSE17705 GSE6532-C
n 230 132
LN Positive 91
59 % DMFS at 10 years
89
70 % DMFS at 10 years
LN Negative 139
85 % DMFS at 10 years
43
75 % DMFS at 10 years
Age NR 61
Age Range NR 40–88
Distant Metastasis at 10 years (n) 62 33
Overall 10 year DMFS 58.7 % 71.1 %
Location MD Anderson, US Guy’s Hosptial, UK, John Radcliffe Hospital, UK & Uppsala University Hospital, Sweden
Submission Group Hatzis, Nuvera Biosciences, Woburn Mass Loi et al., Institut Jules Bordet, Belgium
Affymetrix Chip U133.A U133.A & U133.2
  1. NR-Not Reported